nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0488	0.0809	CbGbCtD
Lisuride—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0459	0.0761	CbGbCtD
Lisuride—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0459	0.0761	CbGbCtD
Lisuride—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0415	0.0688	CbGbCtD
Lisuride—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0415	0.0688	CbGbCtD
Lisuride—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0358	0.0594	CbGbCtD
Lisuride—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0348	0.0576	CbGbCtD
Lisuride—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0314	0.0521	CbGbCtD
Lisuride—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0314	0.0521	CbGbCtD
Lisuride—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.031	0.0514	CbGbCtD
Lisuride—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0292	0.0484	CbGbCtD
Lisuride—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0292	0.0484	CbGbCtD
Lisuride—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0264	0.0437	CbGbCtD
Lisuride—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0264	0.0437	CbGbCtD
Lisuride—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0228	0.0378	CbGbCtD
Lisuride—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0221	0.0367	CbGbCtD
Lisuride—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.02	0.0331	CbGbCtD
Lisuride—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.02	0.0331	CbGbCtD
Lisuride—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0192	0.0318	CbGbCtD
Lisuride—DRD1—nerve—acquired immunodeficiency syndrome	0.00429	0.0576	CbGeAlD
Lisuride—DRD2—nerve—acquired immunodeficiency syndrome	0.00253	0.0341	CbGeAlD
Lisuride—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00212	0.0285	CbGeAlD
Lisuride—HTR2A—nerve—acquired immunodeficiency syndrome	0.00167	0.0225	CbGeAlD
Lisuride—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.00165	0.0222	CbGeAlD
Lisuride—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00149	0.02	CbGeAlD
Lisuride—DRD4—brain—acquired immunodeficiency syndrome	0.00147	0.0197	CbGeAlD
Lisuride—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00142	0.0191	CbGeAlD
Lisuride—DRD3—nervous system—acquired immunodeficiency syndrome	0.00135	0.0181	CbGeAlD
Lisuride—DRD3—central nervous system—acquired immunodeficiency syndrome	0.0013	0.0174	CbGeAlD
Lisuride—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00126	0.017	CbGeAlD
Lisuride—DRD5—nervous system—acquired immunodeficiency syndrome	0.00126	0.017	CbGeAlD
Lisuride—DRD5—central nervous system—acquired immunodeficiency syndrome	0.00122	0.0163	CbGeAlD
Lisuride—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00117	0.0157	CbGeAlD
Lisuride—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00115	0.0155	CbGeAlD
Lisuride—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00114	0.0153	CbGeAlD
Lisuride—DRD2—retina—acquired immunodeficiency syndrome	0.00105	0.0141	CbGeAlD
Lisuride—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00104	0.0139	CbGeAlD
Lisuride—DRD3—brain—acquired immunodeficiency syndrome	0.00103	0.0138	CbGeAlD
Lisuride—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.00101	0.0136	CbGeAlD
Lisuride—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000997	0.0134	CbGeAlD
Lisuride—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000975	0.0131	CbGeAlD
Lisuride—DRD5—brain—acquired immunodeficiency syndrome	0.000965	0.013	CbGeAlD
Lisuride—DRD1—nervous system—acquired immunodeficiency syndrome	0.000965	0.013	CbGeAlD
Lisuride—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000929	0.0125	CbGeAlD
Lisuride—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000928	0.0125	CbGeAlD
Lisuride—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00091	0.0122	CbGeAlD
Lisuride—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00089	0.012	CbGeAlD
Lisuride—HTR2B—blood—acquired immunodeficiency syndrome	0.000867	0.0117	CbGeAlD
Lisuride—Cough—Stavudine—acquired immunodeficiency syndrome	0.00084	0.00378	CcSEcCtD
Lisuride—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.000837	0.00376	CcSEcCtD
Lisuride—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000832	0.00374	CcSEcCtD
Lisuride—Cough—Abacavir—acquired immunodeficiency syndrome	0.000827	0.00372	CcSEcCtD
Lisuride—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000822	0.0037	CcSEcCtD
Lisuride—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.000819	0.00368	CcSEcCtD
Lisuride—Weight increased—Saquinavir—acquired immunodeficiency syndrome	0.000818	0.00368	CcSEcCtD
Lisuride—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.000817	0.00367	CcSEcCtD
Lisuride—Weight decreased—Saquinavir—acquired immunodeficiency syndrome	0.000813	0.00366	CcSEcCtD
Lisuride—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000807	0.00363	CcSEcCtD
Lisuride—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.000804	0.00362	CcSEcCtD
Lisuride—HTR2B—vagina—acquired immunodeficiency syndrome	0.000804	0.0108	CbGeAlD
Lisuride—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.000804	0.00362	CcSEcCtD
Lisuride—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.000801	0.0036	CcSEcCtD
Lisuride—Sweating—Ritonavir—acquired immunodeficiency syndrome	0.000798	0.00359	CcSEcCtD
Lisuride—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000798	0.00359	CcSEcCtD
Lisuride—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000796	0.00358	CcSEcCtD
Lisuride—ADRB1—lung—acquired immunodeficiency syndrome	0.000794	0.0107	CbGeAlD
Lisuride—ADRA1B—brain—acquired immunodeficiency syndrome	0.000791	0.0106	CbGeAlD
Lisuride—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000787	0.00354	CcSEcCtD
Lisuride—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000784	0.00353	CcSEcCtD
Lisuride—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000782	0.0105	CbGeAlD
Lisuride—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.000778	0.0035	CcSEcCtD
Lisuride—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000776	0.00349	CcSEcCtD
Lisuride—ADRA1D—brain—acquired immunodeficiency syndrome	0.000774	0.0104	CbGeAlD
Lisuride—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00077	0.00347	CcSEcCtD
Lisuride—Infection—Abacavir—acquired immunodeficiency syndrome	0.000769	0.00346	CcSEcCtD
Lisuride—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000766	0.00345	CcSEcCtD
Lisuride—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000763	0.00343	CcSEcCtD
Lisuride—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.000762	0.00343	CcSEcCtD
Lisuride—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000761	0.00342	CcSEcCtD
Lisuride—HTR2B—lung—acquired immunodeficiency syndrome	0.00076	0.0102	CbGeAlD
Lisuride—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.000759	0.00342	CcSEcCtD
Lisuride—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000759	0.00341	CcSEcCtD
Lisuride—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000757	0.0102	CbGeAlD
Lisuride—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000753	0.0101	CbGeAlD
Lisuride—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000752	0.00338	CcSEcCtD
Lisuride—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000751	0.00338	CcSEcCtD
Lisuride—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00075	0.00337	CcSEcCtD
Lisuride—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00075	0.0101	CbGeAlD
Lisuride—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000749	0.0101	CbGeAlD
Lisuride—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000749	0.00337	CcSEcCtD
Lisuride—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.000743	0.00334	CcSEcCtD
Lisuride—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000738	0.00332	CcSEcCtD
Lisuride—DRD1—brain—acquired immunodeficiency syndrome	0.000738	0.00991	CbGeAlD
Lisuride—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000736	0.00331	CcSEcCtD
Lisuride—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000736	0.00988	CbGeAlD
Lisuride—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000735	0.00331	CcSEcCtD
Lisuride—Sweating—Lamivudine—acquired immunodeficiency syndrome	0.000733	0.0033	CcSEcCtD
Lisuride—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00073	0.00328	CcSEcCtD
Lisuride—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000729	0.00979	CbGeAlD
Lisuride—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000723	0.00325	CcSEcCtD
Lisuride—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000722	0.0097	CbGeAlD
Lisuride—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000716	0.00322	CcSEcCtD
Lisuride—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000713	0.00321	CcSEcCtD
Lisuride—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000712	0.0032	CcSEcCtD
Lisuride—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00071	0.0032	CcSEcCtD
Lisuride—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00071	0.00319	CcSEcCtD
Lisuride—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000708	0.00952	CbGeAlD
Lisuride—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000707	0.00318	CcSEcCtD
Lisuride—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000704	0.00946	CbGeAlD
Lisuride—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000703	0.00316	CcSEcCtD
Lisuride—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000702	0.00316	CcSEcCtD
Lisuride—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000702	0.00316	CcSEcCtD
Lisuride—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000701	0.00316	CcSEcCtD
Lisuride—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.0007	0.00315	CcSEcCtD
Lisuride—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.0007	0.00315	CcSEcCtD
Lisuride—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000699	0.00314	CcSEcCtD
Lisuride—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000698	0.00314	CcSEcCtD
Lisuride—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000698	0.00314	CcSEcCtD
Lisuride—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000693	0.00312	CcSEcCtD
Lisuride—HTR2A—retina—acquired immunodeficiency syndrome	0.000692	0.0093	CbGeAlD
Lisuride—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00069	0.0031	CcSEcCtD
Lisuride—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000688	0.0031	CcSEcCtD
Lisuride—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000688	0.00309	CcSEcCtD
Lisuride—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000685	0.00308	CcSEcCtD
Lisuride—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000683	0.00307	CcSEcCtD
Lisuride—ADRA2C—blood—acquired immunodeficiency syndrome	0.000683	0.00917	CbGeAlD
Lisuride—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00068	0.00306	CcSEcCtD
Lisuride—Cough—Indinavir—acquired immunodeficiency syndrome	0.000679	0.00305	CcSEcCtD
Lisuride—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000678	0.00305	CcSEcCtD
Lisuride—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000678	0.00911	CbGeAlD
Lisuride—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000678	0.00305	CcSEcCtD
Lisuride—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000677	0.00305	CcSEcCtD
Lisuride—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000675	0.00304	CcSEcCtD
Lisuride—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000673	0.00303	CcSEcCtD
Lisuride—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000673	0.00303	CcSEcCtD
Lisuride—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000672	0.00302	CcSEcCtD
Lisuride—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00067	0.00302	CcSEcCtD
Lisuride—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00067	0.00301	CcSEcCtD
Lisuride—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000668	0.00301	CcSEcCtD
Lisuride—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000667	0.003	CcSEcCtD
Lisuride—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000667	0.003	CcSEcCtD
Lisuride—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00066	0.00297	CcSEcCtD
Lisuride—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00066	0.00297	CcSEcCtD
Lisuride—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00066	0.00297	CcSEcCtD
Lisuride—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000659	0.00297	CcSEcCtD
Lisuride—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000658	0.00884	CbGeAlD
Lisuride—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000655	0.00294	CcSEcCtD
Lisuride—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000652	0.00293	CcSEcCtD
Lisuride—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000651	0.00293	CcSEcCtD
Lisuride—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00065	0.00293	CcSEcCtD
Lisuride—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00065	0.00292	CcSEcCtD
Lisuride—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00065	0.00292	CcSEcCtD
Lisuride—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000649	0.00292	CcSEcCtD
Lisuride—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000649	0.00292	CcSEcCtD
Lisuride—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000648	0.00292	CcSEcCtD
Lisuride—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000648	0.00291	CcSEcCtD
Lisuride—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000641	0.00289	CcSEcCtD
Lisuride—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000638	0.00287	CcSEcCtD
Lisuride—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000633	0.0085	CbGeAlD
Lisuride—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000632	0.00284	CcSEcCtD
Lisuride—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000631	0.00284	CcSEcCtD
Lisuride—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000631	0.00848	CbGeAlD
Lisuride—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000631	0.00284	CcSEcCtD
Lisuride—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00063	0.00283	CcSEcCtD
Lisuride—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000626	0.00282	CcSEcCtD
Lisuride—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000624	0.00281	CcSEcCtD
Lisuride—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000623	0.0028	CcSEcCtD
Lisuride—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000622	0.0028	CcSEcCtD
Lisuride—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000622	0.0028	CcSEcCtD
Lisuride—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00062	0.00279	CcSEcCtD
Lisuride—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000618	0.00278	CcSEcCtD
Lisuride—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000618	0.00278	CcSEcCtD
Lisuride—DRD2—lung—acquired immunodeficiency syndrome	0.000616	0.00827	CbGeAlD
Lisuride—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000614	0.00276	CcSEcCtD
Lisuride—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000614	0.00276	CcSEcCtD
Lisuride—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000612	0.00275	CcSEcCtD
Lisuride—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000609	0.00274	CcSEcCtD
Lisuride—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000607	0.00816	CbGeAlD
Lisuride—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000607	0.00273	CcSEcCtD
Lisuride—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000605	0.00272	CcSEcCtD
Lisuride—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000605	0.00272	CcSEcCtD
Lisuride—ADRA2C—lung—acquired immunodeficiency syndrome	0.000598	0.00804	CbGeAlD
Lisuride—HTR1B—brain—acquired immunodeficiency syndrome	0.000598	0.00803	CbGeAlD
Lisuride—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000597	0.00269	CcSEcCtD
Lisuride—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000597	0.00268	CcSEcCtD
Lisuride—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000594	0.00267	CcSEcCtD
Lisuride—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000589	0.00265	CcSEcCtD
Lisuride—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000589	0.00265	CcSEcCtD
Lisuride—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000588	0.00265	CcSEcCtD
Lisuride—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000586	0.00263	CcSEcCtD
Lisuride—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000586	0.00263	CcSEcCtD
Lisuride—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000584	0.00263	CcSEcCtD
Lisuride—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000584	0.00263	CcSEcCtD
Lisuride—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000584	0.00263	CcSEcCtD
Lisuride—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000583	0.00262	CcSEcCtD
Lisuride—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00058	0.00261	CcSEcCtD
Lisuride—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000579	0.0026	CcSEcCtD
Lisuride—HTR1D—brain—acquired immunodeficiency syndrome	0.000579	0.00777	CbGeAlD
Lisuride—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000575	0.00259	CcSEcCtD
Lisuride—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000575	0.00259	CcSEcCtD
Lisuride—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000574	0.00258	CcSEcCtD
Lisuride—HTR2C—brain—acquired immunodeficiency syndrome	0.000573	0.0077	CbGeAlD
Lisuride—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000572	0.00257	CcSEcCtD
Lisuride—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00057	0.00257	CcSEcCtD
Lisuride—DRD2—nervous system—acquired immunodeficiency syndrome	0.00057	0.00766	CbGeAlD
Lisuride—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000568	0.00255	CcSEcCtD
Lisuride—Headache—Didanosine—acquired immunodeficiency syndrome	0.000567	0.00255	CcSEcCtD
Lisuride—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000566	0.00255	CcSEcCtD
Lisuride—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000565	0.00254	CcSEcCtD
Lisuride—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000564	0.00254	CcSEcCtD
Lisuride—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000564	0.00254	CcSEcCtD
Lisuride—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000563	0.00253	CcSEcCtD
Lisuride—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000562	0.00253	CcSEcCtD
Lisuride—ADRB1—brain—acquired immunodeficiency syndrome	0.000562	0.00755	CbGeAlD
Lisuride—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000561	0.00253	CcSEcCtD
Lisuride—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00056	0.00252	CcSEcCtD
Lisuride—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000555	0.0025	CcSEcCtD
Lisuride—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000555	0.0025	CcSEcCtD
Lisuride—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000554	0.00745	CbGeAlD
Lisuride—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000552	0.00248	CcSEcCtD
Lisuride—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000552	0.00248	CcSEcCtD
Lisuride—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000549	0.00737	CbGeAlD
Lisuride—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000548	0.00247	CcSEcCtD
Lisuride—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000547	0.00246	CcSEcCtD
Lisuride—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000547	0.00246	CcSEcCtD
Lisuride—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000546	0.00246	CcSEcCtD
Lisuride—ADRA2A—blood—acquired immunodeficiency syndrome	0.000545	0.00732	CbGeAlD
Lisuride—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000543	0.00244	CcSEcCtD
Lisuride—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000543	0.00244	CcSEcCtD
Lisuride—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000542	0.00244	CcSEcCtD
Lisuride—HTR2B—brain—acquired immunodeficiency syndrome	0.000538	0.00723	CbGeAlD
Lisuride—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000537	0.00241	CcSEcCtD
Lisuride—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000536	0.00241	CcSEcCtD
Lisuride—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000535	0.00241	CcSEcCtD
Lisuride—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000535	0.00241	CcSEcCtD
Lisuride—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000534	0.00717	CbGeAlD
Lisuride—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000533	0.0024	CcSEcCtD
Lisuride—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000531	0.00239	CcSEcCtD
Lisuride—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000525	0.00705	CbGeAlD
Lisuride—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000523	0.00235	CcSEcCtD
Lisuride—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000522	0.00235	CcSEcCtD
Lisuride—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000521	0.00234	CcSEcCtD
Lisuride—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000521	0.00234	CcSEcCtD
Lisuride—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000521	0.00234	CcSEcCtD
Lisuride—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000521	0.00234	CcSEcCtD
Lisuride—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00052	0.00699	CbGeAlD
Lisuride—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000519	0.00234	CcSEcCtD
Lisuride—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000519	0.00234	CcSEcCtD
Lisuride—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000518	0.00233	CcSEcCtD
Lisuride—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000518	0.00233	CcSEcCtD
Lisuride—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000517	0.00233	CcSEcCtD
Lisuride—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000517	0.00233	CcSEcCtD
Lisuride—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000515	0.00232	CcSEcCtD
Lisuride—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000513	0.00231	CcSEcCtD
Lisuride—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000513	0.00231	CcSEcCtD
Lisuride—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000512	0.0023	CcSEcCtD
Lisuride—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000512	0.0023	CcSEcCtD
Lisuride—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00051	0.0023	CcSEcCtD
Lisuride—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00051	0.00229	CcSEcCtD
Lisuride—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00228	CcSEcCtD
Lisuride—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000507	0.00228	CcSEcCtD
Lisuride—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000506	0.00228	CcSEcCtD
Lisuride—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000505	0.00678	CbGeAlD
Lisuride—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000501	0.00225	CcSEcCtD
Lisuride—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000501	0.00225	CcSEcCtD
Lisuride—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000499	0.00225	CcSEcCtD
Lisuride—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.00224	CcSEcCtD
Lisuride—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000497	0.00224	CcSEcCtD
Lisuride—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000496	0.00223	CcSEcCtD
Lisuride—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000495	0.00223	CcSEcCtD
Lisuride—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000494	0.00222	CcSEcCtD
Lisuride—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000494	0.00222	CcSEcCtD
Lisuride—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000494	0.00222	CcSEcCtD
Lisuride—Headache—Stavudine—acquired immunodeficiency syndrome	0.000492	0.00221	CcSEcCtD
Lisuride—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000492	0.00221	CcSEcCtD
Lisuride—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000491	0.00221	CcSEcCtD
Lisuride—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000491	0.00221	CcSEcCtD
Lisuride—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00049	0.0022	CcSEcCtD
Lisuride—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000487	0.00219	CcSEcCtD
Lisuride—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000486	0.00653	CbGeAlD
Lisuride—Headache—Abacavir—acquired immunodeficiency syndrome	0.000485	0.00218	CcSEcCtD
Lisuride—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000484	0.00218	CcSEcCtD
Lisuride—HTR1A—brain—acquired immunodeficiency syndrome	0.000482	0.00648	CbGeAlD
Lisuride—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00048	0.00216	CcSEcCtD
Lisuride—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000478	0.00215	CcSEcCtD
Lisuride—ADRA2A—lung—acquired immunodeficiency syndrome	0.000478	0.00642	CbGeAlD
Lisuride—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000473	0.00213	CcSEcCtD
Lisuride—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000473	0.00213	CcSEcCtD
Lisuride—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000472	0.00212	CcSEcCtD
Lisuride—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000471	0.00212	CcSEcCtD
Lisuride—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000465	0.00209	CcSEcCtD
Lisuride—HTR2A—blood—acquired immunodeficiency syndrome	0.000463	0.00622	CbGeAlD
Lisuride—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000462	0.00208	CcSEcCtD
Lisuride—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000461	0.00208	CcSEcCtD
Lisuride—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000458	0.00206	CcSEcCtD
Lisuride—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000458	0.00206	CcSEcCtD
Lisuride—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00205	CcSEcCtD
Lisuride—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000455	0.00205	CcSEcCtD
Lisuride—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000454	0.00204	CcSEcCtD
Lisuride—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000454	0.00204	CcSEcCtD
Lisuride—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000451	0.00203	CcSEcCtD
Lisuride—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00045	0.00605	CbGeAlD
Lisuride—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000446	0.006	CbGeAlD
Lisuride—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.002	CcSEcCtD
Lisuride—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000443	0.00595	CbGeAlD
Lisuride—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000442	0.00594	CbGeAlD
Lisuride—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000441	0.00198	CcSEcCtD
Lisuride—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000441	0.00198	CcSEcCtD
Lisuride—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00044	0.00198	CcSEcCtD
Lisuride—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000437	0.00197	CcSEcCtD
Lisuride—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.00197	CcSEcCtD
Lisuride—DRD2—brain—acquired immunodeficiency syndrome	0.000436	0.00585	CbGeAlD
Lisuride—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000435	0.00195	CcSEcCtD
Lisuride—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.00195	CcSEcCtD
Lisuride—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000433	0.00195	CcSEcCtD
Lisuride—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00043	0.00194	CcSEcCtD
Lisuride—HTR2A—vagina—acquired immunodeficiency syndrome	0.000429	0.00577	CbGeAlD
Lisuride—CYP3A4—blood—acquired immunodeficiency syndrome	0.000429	0.00576	CbGeAlD
Lisuride—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000428	0.00192	CcSEcCtD
Lisuride—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000426	0.00572	CbGeAlD
Lisuride—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000424	0.00191	CcSEcCtD
Lisuride—ADRA2C—brain—acquired immunodeficiency syndrome	0.000424	0.00569	CbGeAlD
Lisuride—CYP2D6—blood—acquired immunodeficiency syndrome	0.000422	0.00567	CbGeAlD
Lisuride—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000421	0.00189	CcSEcCtD
Lisuride—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000421	0.00189	CcSEcCtD
Lisuride—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Lisuride—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Lisuride—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.00187	CcSEcCtD
Lisuride—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.00185	CcSEcCtD
Lisuride—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000409	0.0055	CbGeAlD
Lisuride—HTR2A—lung—acquired immunodeficiency syndrome	0.000406	0.00546	CbGeAlD
Lisuride—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000404	0.00182	CcSEcCtD
Lisuride—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000402	0.00181	CcSEcCtD
Lisuride—Headache—Indinavir—acquired immunodeficiency syndrome	0.000398	0.00179	CcSEcCtD
Lisuride—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000397	0.00178	CcSEcCtD
Lisuride—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000381	0.00172	CcSEcCtD
Lisuride—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00171	CcSEcCtD
Lisuride—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00038	0.00171	CcSEcCtD
Lisuride—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000376	0.00505	CbGeAlD
Lisuride—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.00169	CcSEcCtD
Lisuride—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.00165	CcSEcCtD
Lisuride—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00164	CcSEcCtD
Lisuride—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000362	0.00486	CbGeAlD
Lisuride—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00162	CcSEcCtD
Lisuride—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00158	CcSEcCtD
Lisuride—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.00157	CcSEcCtD
Lisuride—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000348	0.00468	CbGeAlD
Lisuride—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000343	0.0046	CbGeAlD
Lisuride—ADRA2A—brain—acquired immunodeficiency syndrome	0.000338	0.00454	CbGeAlD
Lisuride—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.00152	CcSEcCtD
Lisuride—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.00152	CcSEcCtD
Lisuride—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000335	0.0045	CbGeAlD
Lisuride—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.0015	CcSEcCtD
Lisuride—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.00033	0.00443	CbGeAlD
Lisuride—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000327	0.00439	CbGeAlD
Lisuride—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.00146	CcSEcCtD
Lisuride—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.00145	CcSEcCtD
Lisuride—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00144	CcSEcCtD
Lisuride—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00139	CcSEcCtD
Lisuride—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00137	CcSEcCtD
Lisuride—HTR2A—brain—acquired immunodeficiency syndrome	0.000287	0.00386	CbGeAlD
Lisuride—CYP2D6—brain—acquired immunodeficiency syndrome	0.000262	0.00352	CbGeAlD
Lisuride—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.76e-05	0.000376	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.74e-05	0.000374	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.74e-05	0.000374	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.73e-05	0.000373	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.73e-05	0.000372	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.72e-05	0.000371	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.72e-05	0.000371	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.72e-05	0.000371	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.72e-05	0.000371	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.72e-05	0.000371	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.72e-05	0.000371	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.7e-05	0.00037	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.7e-05	0.000369	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.67e-05	0.000367	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.67e-05	0.000366	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.67e-05	0.000366	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.66e-05	0.000366	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.66e-05	0.000366	CbGpPWpGaD
Lisuride—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.62e-05	0.000362	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.61e-05	0.00036	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.61e-05	0.00036	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.61e-05	0.00036	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.6e-05	0.000359	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.58e-05	0.000357	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.57e-05	0.000356	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.55e-05	0.000355	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.54e-05	0.000354	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.52e-05	0.000352	CbGpPWpGaD
Lisuride—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.52e-05	0.000352	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.48e-05	0.000348	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.48e-05	0.000347	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.45e-05	0.000345	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.45e-05	0.000345	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.44e-05	0.000344	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.44e-05	0.000344	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.43e-05	0.000343	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.43e-05	0.000342	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.43e-05	0.000342	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.43e-05	0.000342	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.42e-05	0.000342	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.41e-05	0.00034	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.41e-05	0.00034	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.4e-05	0.00034	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.4e-05	0.000339	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.39e-05	0.000338	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	3.38e-05	0.000338	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.37e-05	0.000337	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.37e-05	0.000337	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.36e-05	0.000335	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.35e-05	0.000335	CbGpPWpGaD
Lisuride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.29e-05	0.000328	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.28e-05	0.000328	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.28e-05	0.000327	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.27e-05	0.000326	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.25e-05	0.000324	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.25e-05	0.000324	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.24e-05	0.000324	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.22e-05	0.000322	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.2e-05	0.00032	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.2e-05	0.00032	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.2e-05	0.00032	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.2e-05	0.00032	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.18e-05	0.000318	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	3.16e-05	0.000316	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.16e-05	0.000315	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	3.16e-05	0.000315	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.14e-05	0.000313	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.13e-05	0.000313	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	3.13e-05	0.000313	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.13e-05	0.000312	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.11e-05	0.000311	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.11e-05	0.000311	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.11e-05	0.00031	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.11e-05	0.00031	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.09e-05	0.000308	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.08e-05	0.000308	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.08e-05	0.000307	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.07e-05	0.000306	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.06e-05	0.000306	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.97e-05	0.000297	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.96e-05	0.000295	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.92e-05	0.000292	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.92e-05	0.000292	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.89e-05	0.000289	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.89e-05	0.000289	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.88e-05	0.000288	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.87e-05	0.000287	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.85e-05	0.000285	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.84e-05	0.000284	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.84e-05	0.000283	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.83e-05	0.000283	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.83e-05	0.000282	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.81e-05	0.00028	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.8e-05	0.00028	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.8e-05	0.00028	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.79e-05	0.000279	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.79e-05	0.000279	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.79e-05	0.000279	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.000278	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.78e-05	0.000278	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.78e-05	0.000278	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.76e-05	0.000276	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.75e-05	0.000274	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.74e-05	0.000274	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.71e-05	0.00027	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.7e-05	0.00027	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.7e-05	0.00027	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.7e-05	0.00027	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.66e-05	0.000266	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.66e-05	0.000266	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.66e-05	0.000266	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.66e-05	0.000266	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.62e-05	0.000262	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.61e-05	0.000261	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.58e-05	0.000258	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.58e-05	0.000258	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.57e-05	0.000256	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.57e-05	0.000256	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	2.56e-05	0.000256	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.55e-05	0.000254	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.54e-05	0.000254	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.51e-05	0.000251	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.51e-05	0.000251	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.47e-05	0.000247	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.47e-05	0.000247	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.46e-05	0.000246	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.45e-05	0.000245	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.45e-05	0.000245	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.44e-05	0.000244	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.44e-05	0.000244	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.43e-05	0.000243	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.42e-05	0.000242	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.41e-05	0.000241	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.41e-05	0.000241	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.4e-05	0.00024	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.4e-05	0.00024	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.4e-05	0.00024	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.37e-05	0.000236	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.37e-05	0.000236	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.36e-05	0.000236	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.33e-05	0.000233	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.31e-05	0.000231	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.23e-05	0.000222	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.22e-05	0.000222	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.2e-05	0.00022	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.2e-05	0.000219	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.2e-05	0.000219	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.2e-05	0.000219	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000219	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.19e-05	0.000219	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.18e-05	0.000217	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000217	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.16e-05	0.000215	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.15e-05	0.000215	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.15e-05	0.000215	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.14e-05	0.000213	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.12e-05	0.000212	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.11e-05	0.000211	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.09e-05	0.000209	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.08e-05	0.000208	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.06e-05	0.000206	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.06e-05	0.000205	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.05e-05	0.000205	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.03e-05	0.000202	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.02e-05	0.000202	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2e-05	0.0002	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.99e-05	0.000199	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.99e-05	0.000199	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.000198	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.96e-05	0.000196	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.96e-05	0.000196	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000194	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000193	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.93e-05	0.000192	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.91e-05	0.000191	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.9e-05	0.00019	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.87e-05	0.000187	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.000186	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000186	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.85e-05	0.000185	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000184	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.84e-05	0.000183	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.82e-05	0.000182	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000181	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000181	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.81e-05	0.000181	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000178	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000178	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000168	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000167	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.65e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.000164	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.62e-05	0.000162	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.62e-05	0.000162	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.58e-05	0.000158	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.00015	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000148	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.48e-05	0.000147	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000147	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.45e-05	0.000145	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.44e-05	0.000144	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000143	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000142	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000136	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.36e-05	0.000136	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.28e-05	0.000128	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.28e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000127	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.26e-05	0.000126	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.26e-05	0.000126	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000116	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.15e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000114	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000114	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.11e-05	0.00011	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.1e-05	0.00011	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.1e-05	0.00011	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.09e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000106	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000105	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000105	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.71e-06	9.7e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.66e-06	9.65e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.55e-06	9.54e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.51e-06	9.5e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.72e-06	8.71e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.69e-06	8.68e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.65e-06	8.64e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.53e-06	8.52e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.4e-06	8.39e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	8.35e-06	8.35e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.02e-06	8.01e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.56e-06	7.55e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.46e-06	7.45e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.46e-06	7.45e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.8e-06	6.79e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.73e-06	6.73e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.5e-06	6.49e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.47e-06	6.46e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.29e-06	6.28e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.19e-06	6.18e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.71e-06	5.7e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.62e-06	5.61e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	5.46e-06	5.46e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.11e-06	5.1e-05	CbGpPWpGaD
